Abstract
Objective: This study aims to explore in detail, the mechanism of the carbon monoxide releasing molecule-3 (CORM-3) in regulating the activity of microglia (MG) in the treatment of radiation brain injury (RBI).
Methods: The brain injury models of BV2 cells and Balb/C mice were established and randomly divided into three groups: the normal control group (CON), the single radiation group (RAD), and the radiation plus CORM-3 intervention group (RAD+CORM). Immunofluorescence was used to observe the effects on activation of the MG. The expressions of inflammatory factors, such as intercellular adhesion molecule-1 (ICAM-1) and inducible nitric oxide synthase (iNOS), were detected by Western blot. Neuron apoptosis and regeneration in the radiation brain injury (RBI) model were detected by neuronal nuclear antigen (NeuN)+TUNEL and NeuN+BrdU double staining. A Morris water maze was used to assess the spatial learning and memory of the mice.
Results: Within 48 h after radiation, CORM-3 inhibited activation of the MG, blocked the phosphorylation of P38, and increased the expression of ICAM-1 and iNOS. Therefore, CORM-3 might alleviate MG-mediated neuronal apoptosis and promote neural regeneration in the subgranular zone (SGZ) of the dentate gyrus of the hippocampus. CORM-3 could increase the swimming distance and platform-stay time of the mice in the target platform quadrant after radiation.
Conclusion: CORM-3 could effectively improve the inflammatory response induced by activation of the MG, reduce neuronal apoptosis, promote neural regeneration, and improve the learning and memory performance of mice after radiation.
Keywords: Microglia cells, radiation brain injury, inflammation, carbon monoxide, nerve regeneration, brain parenchyma.
[http://dx.doi.org/10.1126/science.1092864] [PMID: 14657479]
[http://dx.doi.org/10.1007/s10753-009-9162-y] [PMID: 19842024]
[http://dx.doi.org/10.1093/neuonc/not221] [PMID: 24305723]
[http://dx.doi.org/10.1016/S0006-8993(03)02278-9] [PMID: 12676365]
[http://dx.doi.org/10.3748/wjg.v13.i46.6183] [PMID: 18069757]
[http://dx.doi.org/10.1002/jnr.490310405] [PMID: 1578513]
[http://dx.doi.org/10.1097/CCM.0b013e31822f0d64] [PMID: 21926571]
[http://dx.doi.org/10.1667/RR3369.1] [PMID: 16187784]
[http://dx.doi.org/10.1111/j.1460-9568.2005.04342.x] [PMID: 16197520]
[http://dx.doi.org/10.1016/j.freeradbiomed.2011.11.035] [PMID: 22210380]
[http://dx.doi.org/10.1371/journal.pone.0060672] [PMID: 23593279]
[http://dx.doi.org/10.1186/1471-2202-12-49] [PMID: 21615929]
[http://dx.doi.org/10.1007/s12035-010-8105-9] [PMID: 20195798]
[http://dx.doi.org/10.1016/j.bcp.2005.10.042] [PMID: 16329999]
[http://dx.doi.org/10.1097/ALN.0b013e318286d085] [PMID: 23358127]
[http://dx.doi.org/10.1007/s11060-010-0282-x] [PMID: 20617366]
[http://dx.doi.org/10.1152/ajpheart.00747.2005] [PMID: 16199477]